Harvest Portfolios Group Inc. Amgen Inc Transaction History

Harvest Portfolios Group Inc.

$2.98 Billion
Q4 2024

A detailed history of Harvest Portfolios Group Inc. transactions in Amgen Inc stock. As of the latest transaction made, Harvest Portfolios Group Inc. holds 205,491 shares of AMGN stock, worth $65.5 Million. This represents 1.8% of its overall portfolio holdings.

Number of Shares

205,491

Previous 171,339 19.93%

Holding current value

$65.5 Million

Previous $55.2 Million 2.99%

% of portfolio

1.8%

Previous 1.84%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$258.78 - $328.31 $8.84 Million - $11.2 Million	34,152 Added 19.93%	205,491 $53.6 Million
Q3 2024 Oct 30, 2024	SELL	$309.38 - $337.38 $4.64 Million - $5.06 Million	-15,004 Reduced 8.05%	171,339 $55.2 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $291,652 - $354,434	1,110 Added 0.6%	186,343 $58.2 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $50,547 - $61,017	188 Added 0.1%	185,233 $52.7 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $8.82 Million - $9.96 Million	-34,511 Reduced 15.72%	185,045 $53.3 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $1.31 Million - $1.62 Million	-5,980 Reduced 2.65%	219,556 $59 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $4.77 Million - $5.64 Million	22,260 Added 10.95%	225,536 $50.1 Million
Q1 2023 May 18, 2023	BUY	$225.79 - $275.2 $8 Million - $9.75 Million	35,415 Added 21.1%	203,276 $49.1 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $38.4 Million - $48.8 Million	167,861 New	167,861 $0

Others Institutions Holding AMGN

# of Institutions

3,182

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Portfolios Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harvest Portfolios Group Inc. with notifications on news.

Account

Harvest Portfolios Group Inc. Amgen Inc Transaction History